NEW YORK, June 24, 2021 /PRNewswire/ -- The global benign prostatic hyperplasia treatment market is expected to reach a value of around $17 billion by 2030. The surging geriatric population, rising incidence of prostate cancer, growing awareness about prostate cancer and its treatment...
from PR Newswire: https://ift.tt/3gYbDoB
No comments:
Post a Comment